Page last updated: 2024-09-04

cinacalcet and eplerenone

cinacalcet has been researched along with eplerenone in 3 studies

Compound Research Comparison

Studies (cinacalcet)	Trials (cinacalcet)	Recent Studies (post-2010) (cinacalcet)	Studies (eplerenone)	Trials (eplerenone)	Recent Studies (post-2010) (eplerenone)
1,070	155	627	1,036	172	577

Protein Interaction Comparison

Protein	Taxonomy	cinacalcet (IC50)	eplerenone (IC50)
Mineralocorticoid receptor	Homo sapiens (human)		0.668
Mineralocorticoid receptor	Rattus norvegicus (Norway rat)		0.0398

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fottner, C; Weber, MM	1
Brown, JM; Heydarpour, M; Mannstadt, M; Parksook, WW; Turchin, A; Vaidya, A	1

Reviews

2 review(s) available for cinacalcet and eplerenone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[The latest developments in endocrinology 2004/2005]. Medizinische Klinik (Munich, Germany : 1983), 2006, Jan-15, Volume: 101, Issue:1 Topics: Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Endocrinology; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypogonadism; Hypothyroidism; Male; Naphthalenes; Neuroendocrine Tumors; Organometallic Compounds; Osteoporosis, Postmenopausal; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiography, Abdominal; Spironolactone; Teriparatide; Testosterone; Testosterone Congeners; Thiophenes; Time Factors; Tomography, X-Ray Computed	2006

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

[The latest developments in endocrinology 2004/2005].

Medizinische Klinik (Munich, Germany : 1983), 2006, Jan-15, Volume: 101, Issue:1

Topics: Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Endocrinology; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypogonadism; Hypothyroidism; Male; Naphthalenes; Neuroendocrine Tumors; Organometallic Compounds; Osteoporosis, Postmenopausal; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiography, Abdominal; Spironolactone; Teriparatide; Testosterone; Testosterone Congeners; Thiophenes; Time Factors; Tomography, X-Ray Computed

2006

Trials

1 trial(s) available for cinacalcet and eplerenone

Article	Year
Evaluating the clinical and mechanistic effects of eplerenone and amiloride monotherapy, and combination therapy with cinacalcet, in primary hyperparathyroidism: A placebo-controlled randomized trial. Clinical endocrinology, 2023, Volume: 98, Issue:4 Topics: Aldosterone; Amiloride; Calcium; Cinacalcet; Eplerenone; Female; Humans; Hyperparathyroidism, Primary; Male; Parathyroid Hormone; Renin	2023